Neridronate (Synonyms: Neridronate) |
カタログ番号GC36723 |
ネリドロネートは、骨形成不全症(OI)および骨ページェット病(PDB)の治療薬としてイタリアで認可されたアミノビスフォスフォネートです。ネリドロネートは、骨粗鬆症、アルゴジストロフィー、悪性高カルシウム血症、骨転移などの他の骨格疾患にも有効です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 79778-41-9
Sample solution is provided at 25 µL, 10mM.
Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget's disease of bone (PDB). Neridronate is effective also in other skeletal diseases such as osteoporosis, algodystrophy, hypercalcemia of malignancy, and bone metastases[1][2].
[1]. Gatti D, et al. Clinical development of neridronate: potential for new applications. Ther Clin Risk Manag. 2013;9:139-47. [2]. Guiducci L, et al. Monthly Intramuscular Neridronate for the Treatment of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study. Int J Endocrinol. 2019 Feb 6;2019:9802827.
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *